We are live on
!
Find out more
CCM
Cinctive Capital Management Portfolio holdings
AUM
$1.53B
1-Year Est. Return
48.83%
This Fund
S&P 500
This Quarter
Est. Return
+1.3%
1 Year Est. Return
+48.83%
3 Year Est. Return
+143.95%
5 Year Est. Return
+199.46%
10 Year Est. Return
–
AUM
$2.04B
AUM Growth
-$97.4M
(-4.6%)
Cap. Flow
-$113M
Cap. Flow
% of AUM
-5.55%
Top 10 Holdings %
Top 10 Hldgs %
11.33%
Holding
698
New
210
Increased
118
Reduced
125
Closed
177
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$18.9M |
| 2 |
Baxter International
BAX
|
+$18.2M |
| 3 |
EXE
Expand Energy Corp
EXE
|
+$17M |
| 4 |
T-Mobile US
TMUS
|
+$16.5M |
| 5 |
Merck
MRK
|
+$16.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elevance Health
ELV
|
+$22.2M |
| 2 |
PLAN
Anaplan, Inc.
PLAN
|
+$21M |
| 3 |
Paycom
PAYC
|
+$19.5M |
| 4 |
Canadian Natural Resources
CNQ
|
+$14.1M |
| 5 |
Gilead Sciences
GILD
|
+$13.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.02% |
| 2 | Technology | 17.87% |
| 3 | Consumer Discretionary | 12.08% |
| 4 | Financials | 10% |
| 5 | Energy | 7.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
CALL
Glaukos
GKOS
$9.83B
| $1.91M | 0.09% |
+39,700
| New | +$2.2M |
|
|
EXAS
302
CALL
DELISTED
Exact Sciences
EXAS
| $1.91M | 0.09% |
+20,000
| New | +$2.11M |
|
303
Pulmonx
LUNG
$68.8M
| $1.91M | 0.09% |
53,008
+42,109
| +386% | +$1.66M |
|
|
WCN
304
Waste Connections
WCN
$42.2B
| $1.9M | 0.09% |
+15,059
| New | +$1.9M |
|
305
Uber
UBER
$143B
| $1.89M | 0.09% |
42,097
-25,076
| -37% | -$1.1M |
|
|
SLGC
306
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $1.88M | 0.09% |
+152,068
| New | +$1.71M |
|
|
RCM
307
DELISTED
R1 RCM Inc. Common Stock
RCM
| $1.88M | 0.09% |
85,295
+70,295
| +469% | +$1.45M |
|
308
Sonos
SONO
$1.73B
| $1.87M | 0.09% |
57,721
-102,509
| -64% | -$3.69M |
|
309
Agilent Technologies
A
$39.1B
| $1.86M | 0.09% |
11,834
-22,706
| -66% | -$3.67M |
|
310
SentinelOne
S
$6.53B
| $1.86M | 0.09% |
34,800
-66,700
| -66% | -$3.66M |
|
311
Riskified
RSKD
$694M
| $1.84M | 0.09% |
+80,577
| New | +$2.26M |
|
312
Ingredion
INGR
$6.27B
| $1.83M | 0.09% |
+20,615
| New | +$1.82M |
|
|
LFG.WS
313
DELISTED
Archaea Energy Inc. Warrants, exercisable for one share of Class A common stock at an exercise price
LFG.WS
| $1.83M | 0.09% |
+250,000
| New | +$1.97M |
|
314
Ashland
ASH
$3.33B
| $1.83M | 0.09% |
20,521
+12,521
| +157% | +$1.1M |
|
|
STER
315
DELISTED
Sterling Check Corp. Common Stock
STER
| $1.83M | 0.09% |
+70,432
| New | +$1.85M |
|
316
Sabre
SABR
$731M
| $1.82M | 0.09% |
153,700
+58,099
| +61% | +$659K |
|
317
Icon
ICLR
$12.6B
| $1.81M | 0.09% |
+6,899
| New | +$1.68M |
|
318
AstraZeneca
AZN
$263B
| $1.8M | 0.09% |
+15,000
| New | +$1.75M |
|
319
CALL
Waters Corp
WAT
$37B
| $1.79M | 0.09% |
+5,000
| New | +$1.96M |
|
|
OLPX
320
DELISTED
Olaplex Holdings
OLPX
| $1.78M | 0.09% |
+72,500
| New | +$1.78M |
|
321
Vroom Inc
VRM
$39M
| $1.77M | 0.09% |
1,002
+427
| +74% | +$1.09M |
|
322
Yelp
YELP
$1.45B
| $1.76M | 0.09% |
+47,400
| New | +$1.8M |
|
323
Albertsons Companies
ACI
$5.62B
| $1.75M | 0.09% |
+56,365
| New | +$1.48M |
|
|
SAGE
324
DELISTED
Sage Therapeutics
SAGE
| $1.75M | 0.09% |
+39,400
| New | +$1.81M |
|
|
BRSL
325
Brightstar Lottery PLC
BRSL
$1.84B
| $1.74M | 0.09% |
66,200
-3,763
| -5% | -$79.8K |
|
Similar funds
MCP
ICM
FI
FBB
SG
CET
HR
CCP
Cinctive Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Cinctive Capital Management held 698 positions worth $2.04B, down 4.6% from $2.14B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Cinctive Capital Management withdrew a net $113M in Q3 2021, closing 177 positions and reducing 125 holdings. Its most notable exit was Canadian Natural Resources, an estimated $14.1M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Cinctive Capital Management opened a new position in Thermo Fisher Scientific worth $19.7M.
- Cinctive Capital Management's largest Q3 2021 buy was Thermo Fisher Scientific: 34,421 shares worth $19.7M.
- Cinctive Capital Management added most to Eli Lilly in Q3 2021, an estimated $11.2M increase.
- Cinctive Capital Management's biggest Q3 2021 reduction was Elevance Health, cutting an estimated $22.2M.
- Cinctive Capital Management fully exited Canadian Natural Resources in Q3 2021, selling an estimated $14.1M.
- Cinctive Capital Management's ten largest holdings make up 11% of its $2.04B portfolio in Q3 2021.
- Cinctive Capital Management opened 210 new positions and closed 177 in Q3 2021.
- Cinctive Capital Management's portfolio value fell 4.6% quarter-over-quarter to $2.04B.
Based on Cinctive Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.